CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma

Eun-Jung Lee, Seung-Hyun Yang, Kyoung-Jin Kim, Hyejung Cha, Seo Jin Lee, Ji-Hye Kim, Junkyu Song, Kyung-Hee Chun, Jinsil Seong

Cancer Research and Treatment. 2018;50(3):646-657. Published online 2017 July 17 DOI: https://doi.org/10.4143/crt.2016.550

Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma

Eun-Jung Lee, Seung-Hyun Yang, Kyoung-Jin Kim, Hyejung Cha, Seo Jin Lee, Ji-Hye Kim, Junkyu Song, Kyung-Hee Chun, Jinsil Seong

Cancer Research and Treatment. 2018;50(3):646-657

Link1

Link2 Link3

P556 INTER-ALPHA TRYPSIN INHIBITOR HEAVY CHAIN H4 AS DIAGNOSTIC AND PROGNOSTIC INDICATOR IN PATIENTS WITH HEPATITIS B VIRUS ASSOCIATED HEPATOCELLULAR CARCINOMA

S.S. Kim, C.K. Noh, H.J. Cho, S.J. Ahn, S.W. Cho, J.Y. Cheong

Journal of Hepatology. 2014;60(1):S254

Link1 Link2

Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein

M. Gilabert, JL. Raoul

Journal of Hepatocellular Carcinoma. 2018;Volume 5:91-98

Link1 Link2

Inter-alpha inhibitor proteins—biomarker for NEC?

Alan H. Jobe

The Journal of Pediatrics. 2010;157(5):A2

Link1 Link2

Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy

Zafer Akçali, Ebru Akin, Özgür Özyilkan

Cancer. 2002;95(9):2038-2039

Link1 Link2

Predicting the posttransplant prognosis of patients with hepatocellular carcinoma: What lies beneath alpha-fetoprotein?

Edoardo G. Giannini, Vincenzo Savarino

Liver Transplantation. 2013;n/a-n/a

Link1

Serum TGF-β1: A Potential Biomarker for Early Detection of Hepatocellular Carcinoma

Jian He, Yang Liu

EBioMedicine. 2016;12:4-5

Link1 Link2

Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma

Ho Jung An, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Myung Ah Lee, Young Kyoung You, Dong Goo Kim, Eun Sun Jung

Liver Transplantation. 2012;18(12):1406-1414

Link1

CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus-positive patients with resected hepatocellular carcinoma

Anna Kakehashi, Naomi Ishii, Eiji Sugihara, Min Gi, Hideyuki Saya, Hideki Wanibuchi

Cancer Science. 2016;107(5):609-618

Link1

Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib

H.J. Cho, S.S. Kim, S.W. Cho, J.Y. Cheong

Journal of Hepatology. 2017;66(1):S467-S468

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.